- Advertise
- OLE Scientific Interchange Workshops
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
University of Michigan Rogel Cancer Center | Strategic Alliance Partners
Latest from University of Michigan Rogel Cancer Center
Dr. Farrington on the Importance of Genetic Testing in CRC
October 13, 2020
Video
Caroline Farrington, PhD, discusses the importance of genetic testing in colorectal cancer.
Family History Plays Key Role in Germline Testing for Hereditary Breast and Ovarian Cancers
October 12, 2020
Article
Sofia D. Merajver, MD, PhD, discusses the importance of germline testing in patients with breast and ovarian cancer along with how this testing is being used to personalize treatment.
Identifying Genetic Variants, Matching With Targeted Therapies Serve as Next Great Challenge With Germline Testing in Oncology
October 12, 2020
Article
Goutham Narla, MD, PhD, discusses the revolution of genetic testing and how it has led to more accurate and widespread assays for patients with cancer.
Patient Advocacy and Education Are Essential for Optimal Cancer Care
October 11, 2020
Article
Caroline Farrington, PhD, shares her insight as both a researcher and a cancer survivor on the importance of patient advocacy, as well as the proper resources to aid patients through a cancer diagnosis.
PARP Inhibitors Underscore the Need for Routine Germline Testing in Prostate Cancer
September 29, 2020
Article
Ajjai Shivaram Alva, MBBS, discusses the role of PARP inhibitors in prostate cancer, the importance of germline testing, and the need for personalized medicine.
Dr. Vaishampayan on the Safety of Tivozanib Versus Sorafenib in RCC
September 15, 2020
Video
Ulka N. Vaishampayan, MBBS, FAB, discusses the safety of tivozanib versus sorafenib in advanced renal cell carcinoma.